Loading...

Operating Data

Mettler-Toledo International Inc.

Mettler-Toledo International Inc. (MTD)

Healthcare

Year
A/P
2013
Actual
2014
Actual
2015
Actual
2016
Actual
2017
Actual
2018
Actual
2019
Projected
2020
Projected
2021
Projected
2022
Projected
2023
Projected
Revenue 2,378.972,486.032,395.532,508.362,725.092,935.743,064.613,199.153,339.593,486.203,639.25
Revenue (%)
EBITDA 484.83532.26554.81601.00683.18770.92716.20747.64780.46814.73850.49
EBITDA (%)
EBIT 425.60469.36490.84532.27607.15686.38633.76661.58690.63720.95752.60
EBIT (%)
Depreciation 59.2462.9063.9668.7376.0384.5582.4486.0689.8493.7897.90
Depreciation (%)




EBIT (Operating profit)(Operating income)(Operating earning) = GROSS MARGIN (REVENUE - COGS) - OPERATING EXPENSES (R&D, RENT)
EBIT = (1*) (2*) -> operating process (leverage -> interest -> EBT -> tax -> net Income)
EBITDA = GROSS MARGIN (REVENUE - COGS) - OPERATING EXPENSES (R&D, RENT) + Depreciation + amortization
EBITA = (1*) (2*) (3*) (4*) company's CURRENT operating profitability (i.e., how much profit it makes with its present assets and its operations on the products it produces and sells, as well as providing a proxy for cash flow) -> performance of a company
(1*) discounting the effects of interest payments from different forms of financing (by ignoring interest payments),
(2*) political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill)
(3*) collections of assets (by ignoring depreciation of assets)
(4*) different takeover histories (by ignoring amortization often stemming from goodwill)